On the public citation graph

Non‐Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co‐Delivery of Cas9 mRNA and sgRNA

https://doi.org/10.1002/anie.201610209
0 signed · 580 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/adma.201505822openalex-snapshot
Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery
inferredcites →https://doi.org/10.1002/ange.201203263openalex-snapshot
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
inferredcites →https://doi.org/10.1002/ange.201506030openalex-snapshot
Self‐Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing
inferredcites →https://doi.org/10.1002/ange.201603648openalex-snapshot
A Single Methylene Group in Oligoalkylamine‐Based Cationic Polymers and Lipids Promotes Enhanced mRNA Delivery
inferredcites →https://doi.org/10.1002/ange.201608450openalex-snapshot
Polymer–Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs
inferredcites →https://doi.org/10.1002/anie.201203263openalex-snapshot
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
inferredcites →https://doi.org/10.1002/anie.201506030openalex-snapshot
Self‐Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing
inferredcites →https://doi.org/10.1002/anie.201603648openalex-snapshot
A Single Methylene Group in Oligoalkylamine‐Based Cationic Polymers and Lipids Promotes Enhanced mRNA Delivery
inferredcites →https://doi.org/10.1002/anie.201608450openalex-snapshot
Polymer–Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs
inferredcites →https://doi.org/10.1007/978-1-60761-753-2_15openalex-snapshot
A Rapid and General Assay for Monitoring Endogenous Gene Modification
inferredcites →https://doi.org/10.1016/j.cell.2014.09.014openalex-snapshot
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
inferredcites →https://doi.org/10.1016/j.cell.2015.02.038openalex-snapshot
Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
inferredcites →https://doi.org/10.1016/j.jconrel.2014.04.047openalex-snapshot
Designer lipids for drug delivery: From heads to tails
inferredcites →https://doi.org/10.1021/acs.nanolett.5b02428openalex-snapshot
Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo
inferredcites →https://doi.org/10.1021/acs.nanolett.5b02497openalex-snapshot
Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
inferredcites →https://doi.org/10.1021/jacs.5b03429openalex-snapshot
Rapid Synthesis of a Lipocationic Polyester Library via Ring-Opening Polymerization of Functional Valerolactones for Efficacious siRNA Delivery
inferredcites →https://doi.org/10.1021/jp3088786openalex-snapshot
Correction to “Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core”
inferredcites →https://doi.org/10.1021/nn301922xopenalex-snapshot
In Vitro–In Vivo Translation of Lipid Nanoparticles for Hepatocellular siRNA Delivery
inferredcites →https://doi.org/10.1038/nature13589openalex-snapshot
CRISPR-mediated direct mutation of cancer genes in the mouse liver
inferredcites →https://doi.org/10.1038/nature13906openalex-snapshot
Rapid modelling of cooperating genetic events in cancer through somatic genome editing
inferredcites →https://doi.org/10.1038/nbt.1602openalex-snapshot
Rational design of cationic lipids for siRNA delivery
inferredcites →https://doi.org/10.1038/nbt.2612openalex-snapshot
Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
inferredcites →https://doi.org/10.1038/nbt.2842openalex-snapshot
CRISPR-Cas systems for editing, regulating and targeting genomes
inferredcites →https://doi.org/10.1038/nbt.2884openalex-snapshot
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
inferredcites →https://doi.org/10.1038/nbt.3081openalex-snapshot
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
inferredcites →https://doi.org/10.1038/nbt.3298openalex-snapshot
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
inferredcites →https://doi.org/10.1038/nbt1402openalex-snapshot
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
inferredcites →https://doi.org/10.1038/nmat3765openalex-snapshot
Delivery materials for siRNA therapeutics
inferredcites →https://doi.org/10.1038/nprot.2013.143openalex-snapshot
Genome engineering using the CRISPR-Cas9 system
inferredcites →https://doi.org/10.1038/nrc3950openalex-snapshot
Applications of the CRISPR–Cas9 system in cancer biology
inferredcites →https://doi.org/10.1039/c2cc31710aopenalex-snapshot
Synthesis and characterization of novel zwitterionic lipids with pH-responsive biophysical properties
inferredcites →https://doi.org/10.1039/c4cc02866jopenalex-snapshot
Sulfated quaternary amine lipids: a new class of inverse charge zwitterlipids
inferredcites →https://doi.org/10.1073/pnas.0910603106openalex-snapshot
Lipid-like materials for low-dose, in vivo gene silencing
inferredcites →https://doi.org/10.1073/pnas.1520244113openalex-snapshot
Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
inferredcites →https://doi.org/10.1073/pnas.1520756113openalex-snapshot
Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model
inferredcites →https://doi.org/10.1073/pnas.1606886113openalex-snapshot
Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells
inferredcites →https://doi.org/10.1126/sciadv.1500454openalex-snapshot
CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
inferredcites →https://doi.org/10.1126/science.1225829openalex-snapshot
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
inferredcites →https://doi.org/10.1126/science.1231143openalex-snapshot
Multiplex Genome Engineering Using CRISPR/Cas Systems
inferredcites →https://doi.org/10.1126/science.1232033openalex-snapshot
RNA-Guided Human Genome Engineering via Cas9
inferredcites →https://doi.org/10.1126/science.aad5143openalex-snapshot
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
inferredcites →https://doi.org/10.1126/science.aad5177openalex-snapshot
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
inferredcites →https://doi.org/10.1126/science.aad5725openalex-snapshot
Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
inferredcites →https://doi.org/10.1186/s13059-015-0680-7openalex-snapshot
A versatile reporter system for CRISPR-mediated chromosomal rearrangements

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4657914openalex-extracted
Delivery of Rna Drugs: Beyond the Liver, More than Vaccine
inferred← citeshttps://doi.org/10.1002/1099-0712(200001/02)10:1<1::aid-amo420>3.0.co;2-yopenalex-snapshot
Advanced functional materials
inferred← citeshttps://doi.org/10.1002/9781119692799.ch12openalex-snapshot
CRISPR/CAS9
inferred← citeshttps://doi.org/10.1002/9781119808527.ch17openalex-snapshot
Nanotechnology and Genetically Modified Organisms for Agricultural Sustainability
inferred← citeshttps://doi.org/10.1002/9781394273270.ch25openalex-snapshot
Modification of Conventional Methods and Modern Plant Breeding Techniques to Enhance Genetic Gain for Future Food Security
inferred← citeshttps://doi.org/10.1002/9783527840816.ch18openalex-snapshot
Engineering Nucleic Acid Structures for Programmable Intracellular Biocomputation
inferred← citeshttps://doi.org/10.1002/adfm.201703036openalex-snapshot
Targeted Delivery of CRISPR/Cas9‐Mediated Cancer Gene Therapy via Liposome‐Templated Hydrogel Nanoparticles
inferred← citeshttps://doi.org/10.1002/adfm.202011068openalex-snapshot
mRNA‐Loaded Lipid‐Like Nanoparticles for Liver Base Editing Via the Optimization of Central Composite Design
inferred← citeshttps://doi.org/10.1002/adfm.202204947openalex-snapshot
A Combinatorial Library of Biodegradable Lipid Nanoparticles Preferentially Deliver mRNA into Tumor Cells to Block Mutant RAS Signaling
inferred← citeshttps://doi.org/10.1002/adfm.202406878openalex-snapshot
An Ultrahydrating Polymer that Protects Protein Therapeutics and RNA‐Lipid Nanoparticles Against Freezing, Heat and Lyophilization Stress
inferred← citeshttps://doi.org/10.1002/adhm.201901487openalex-snapshot
Lipid‐Modified Aminoglycosides for mRNA Delivery to the Liver
inferred← citeshttps://doi.org/10.1002/adhm.202203033openalex-snapshot
High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
inferred← citeshttps://doi.org/10.1002/adhm.202502225openalex-snapshot
Synthesis and Screening of Bispecific Linker‐based Combinatorial Libraries Identified Thiosuccinimide Lipids for mRNA Delivery
inferred← citeshttps://doi.org/10.1002/adma.201700131openalex-snapshot
High‐Contrast Fluorescence Detection of Metastatic Breast Cancer Including Bone and Liver Micrometastases via Size‐Controlled pH‐Activatable Water‐Soluble Probes
inferred← citeshttps://doi.org/10.1002/adma.201705328openalex-snapshot
Advances in Biomaterials for Drug Delivery
inferred← citeshttps://doi.org/10.1002/adma.201805308openalex-snapshot
Dendrimer‐Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I
inferred← citeshttps://doi.org/10.1002/adma.201807748openalex-snapshot
Nanoparticles Containing Oxidized Cholesterol Deliver mRNA to the Liver Microenvironment at Clinically Relevant Doses
inferred← citeshttps://doi.org/10.1002/adma.201901081openalex-snapshot
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
inferred← citeshttps://doi.org/10.1002/adma.201902575openalex-snapshot
Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles
inferred← citeshttps://doi.org/10.1002/adma.201903367openalex-snapshot
Biomaterials as Tools to Decode Immunity
inferred← citeshttps://doi.org/10.1002/adma.202000208openalex-snapshot
Aptamer/Peptide‐Functionalized Genome‐Editing System for Effective Immune Restoration through Reversal of PD‐L1‐Mediated Cancer Immunosuppression
inferred← citeshttps://doi.org/10.1002/adma.202006619openalex-snapshot
All‐In‐One Dendrimer‐Based Lipid Nanoparticles Enable Precise HDR‐Mediated Gene Editing In Vivo
inferred← citeshttps://doi.org/10.1002/adma.202101993openalex-snapshot
Traceable Nano‐Biohybrid Complexes by One‐Step Synthesis as CRISPR‐Chem Vectors for Neurodegenerative Diseases Synergistic Treatment
inferred← citeshttps://doi.org/10.1002/adma.202208018openalex-snapshot
Overcoming the Blood–Brain Barrier for Gene Therapy via Systemic Administration of GSH‐Responsive Silica Nanocapsules
inferred← citeshttps://doi.org/10.1002/adma.202300665openalex-snapshot
Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adma.202303261openalex-snapshot
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adtp.201800085openalex-snapshot
Synthetic Vehicles for Encapsulation and Delivery of CRISPR/Cas9 Gene Editing Machinery
inferred← citeshttps://doi.org/10.1002/adtp.201900061openalex-snapshot
Polyrotaxane Nanocarriers Can Deliver CRISPR/Cas9 Plasmid to Dystrophic Muscle Cells to Successfully Edit the DMD Gene
inferred← citeshttps://doi.org/10.1002/adtp.202000099openalex-snapshot
Nanoplatforms for mRNA Therapeutics
inferred← citeshttps://doi.org/10.1002/adtp.202400231openalex-snapshot
Unlocking the Potential of Chemically Modified Nucleic Acid Therapeutics
inferred← citeshttps://doi.org/10.1002/advs.201700175openalex-snapshot
Genome Editing for Cancer Therapy: Delivery of Cas9 Protein/sgRNA Plasmid via a Gold Nanocluster/Lipid Core–Shell Nanocarrier
inferred← citeshttps://doi.org/10.1002/advs.201801423openalex-snapshot
Multistage Delivery Nanoparticle Facilitates Efficient CRISPR/dCas9 Activation and Tumor Growth Suppression In Vivo
inferred← citeshttps://doi.org/10.1002/advs.201903381openalex-snapshot
Appropriate Delivery of the CRISPR/Cas9 System through the Nonlysosomal Route: Application for Therapeutic Gene Editing
inferred← citeshttps://doi.org/10.1002/advs.202207512openalex-snapshot
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
inferred← citeshttps://doi.org/10.1002/advs.202300195openalex-snapshot
Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine
inferred← citeshttps://doi.org/10.1002/advs.202300502openalex-snapshot
CES1‐Triggered Liver‐Specific Cargo Release of CRISPR/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration
inferred← citeshttps://doi.org/10.1002/advs.75244openalex-snapshot
Enhanced Intracellular Stability and Translation Efficiency of mRNA Drugs by a 2‐arm mRNA Platform
inferred← citeshttps://doi.org/10.1002/anbr.202200082openalex-snapshot
Nonviral Delivery of CRISPR/Cas Systems in mRNA Format
inferred← citeshttps://doi.org/10.1002/ange.201708689openalex-snapshot
Thermo‐triggered Release of CRISPR‐Cas9 System by Lipid‐Encapsulated Gold Nanoparticles for Tumor Therapy
inferred← citeshttps://doi.org/10.1002/ange.201809056openalex-snapshot
Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs
inferred← citeshttps://doi.org/10.1002/ange.201903618openalex-snapshot
Triple‐Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases
inferred← citeshttps://doi.org/10.1002/ange.202005644openalex-snapshot
Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli‐Responsive Vehicles
inferred← citeshttps://doi.org/10.1002/ange.202013927openalex-snapshot
A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo
inferred← citeshttps://doi.org/10.1002/ange.202107036openalex-snapshot
Hypoxia‐Responsive Gene Editing to Reduce Tumor Thermal Tolerance for Mild‐Photothermal Therapy
inferred← citeshttps://doi.org/10.1002/anie.201708689openalex-snapshot
Thermo‐triggered Release of CRISPR‐Cas9 System by Lipid‐Encapsulated Gold Nanoparticles for Tumor Therapy
inferred← citeshttps://doi.org/10.1002/anie.201809056openalex-snapshot
Customizable Lipid Nanoparticle Materials for the Delivery of siRNAs and mRNAs
inferred← citeshttps://doi.org/10.1002/anie.201903618openalex-snapshot
Triple‐Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases
inferred← citeshttps://doi.org/10.1002/anie.202005644openalex-snapshot
Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli‐Responsive Vehicles
inferred← citeshttps://doi.org/10.1002/anie.202013927openalex-snapshot
A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved mRNA Transfection In Vivo
inferred← citeshttps://doi.org/10.1002/anie.202107036openalex-snapshot
Hypoxia‐Responsive Gene Editing to Reduce Tumor Thermal Tolerance for Mild‐Photothermal Therapy
inferred← citeshttps://doi.org/10.1002/bab.2200openalex-snapshot
CRISPR/Cas9 in cancer: An attempt to the present trends and future prospects
inferred← citeshttps://doi.org/10.1002/bies.202000047openalex-snapshot
Cas9 Cuts and Consequences; Detecting, Predicting, and Mitigating CRISPR/Cas9 On‐ and Off‐Target Damage
inferred← citeshttps://doi.org/10.1002/bmm2.12025openalex-snapshot
Development of delivery strategies for CRISPR‐Cas9 genome editing
inferred← citeshttps://doi.org/10.1002/bmm2.12116openalex-snapshot
Principles of lipid nanoparticle design for mRNA delivery
inferred← citeshttps://doi.org/10.1002/btpr.2484openalex-snapshot
The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups
inferred← citeshttps://doi.org/10.1002/cac2.12366openalex-snapshot
Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
inferred← citeshttps://doi.org/10.1002/cbic.202100544openalex-snapshot
Dibenzocyclooctyne‐Branched Primer Assembled Gene Nanovector and Its Potential Applications in Genome Editing
inferred← citeshttps://doi.org/10.1002/cbic.202400481openalex-snapshot
In Vivo Delivery Processes and Development Strategies of Lipid Nanoparticles
inferred← citeshttps://doi.org/10.1002/cbic.70413openalex-snapshot
Compositional Optimization of CRISPR/Cas9 Lipid Nanoparticles for Efficient Knockdown of Target Genes
inferred← citeshttps://doi.org/10.1002/jbm.a.37705openalex-snapshot
Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length
inferred← citeshttps://doi.org/10.1002/jgm.3082openalex-snapshot
Creating cell and animal models of human disease by genome editing using CRISPR/Cas9
inferred← citeshttps://doi.org/10.1002/jgm.70091openalex-snapshot
CRISPR–Cas Systems in Human Disease Therapy: Advances, Clinical Applications, Limitations, and Future Directions
inferred← citeshttps://doi.org/10.1002/jmv.27046openalex-snapshot
Reversible switching of primary cells between normal and malignant state by oncogenic virus KSHV and CRISPR/Cas9‐mediated targeting of a major viral latent protein
inferred← citeshttps://doi.org/10.1002/mabi.202100048openalex-snapshot
Zinc(II)‐Dipicolylamine Analogs Mediated PEI1.8k/pDNA Vector: Effect of Ligand Structure on the Gene Transport Process
inferred← citeshttps://doi.org/10.1002/marc.201800068openalex-snapshot
Cationic Polymer‐Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing
inferred← citeshttps://doi.org/10.1002/slct.202200415openalex-snapshot
Green Synthesis of Zinc Oxide Nanoparticles Mediated from Cassia renigera Bark and Detect Its Effects on Four Varieties of Rice
inferred← citeshttps://doi.org/10.1002/smll.201805097openalex-snapshot
Branched‐Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pH
inferred← citeshttps://doi.org/10.1002/smll.202100546openalex-snapshot
Supramolecular Nanosubstrate‐Mediated Delivery for CRISPR/Cas9 Gene Disruption and Deletion
inferred← citeshttps://doi.org/10.1002/smll.202511489openalex-snapshot
Extrahepatic Gene Editing In Vivo Using Organic Solvent‐Free Lipid Nanoparticles
inferred← citeshttps://doi.org/10.1002/smsc.202400192openalex-snapshot
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing
inferred← citeshttps://doi.org/10.1002/smtd.201700375openalex-snapshot
State‐of‐the‐Art Design and Rapid‐Mixing Production Techniques of Lipid Nanoparticles for Nucleic Acid Delivery
inferred← citeshttps://doi.org/10.1002/smtd.202100935openalex-snapshot
CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis
inferred← citeshttps://doi.org/10.1002/smtd.202401632openalex-snapshot
Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
inferred← citeshttps://doi.org/10.1002/wnan.1530openalex-snapshot
Nanoscale platforms for messenger RNA delivery
inferred← citeshttps://doi.org/10.1002/wnan.1609openalex-snapshot
Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
inferred← citeshttps://doi.org/10.1002/wnan.1773openalex-snapshot
Combinational application of metal–organic frameworks‐based nanozyme and nucleic acid delivery in cancer therapy
inferred← citeshttps://doi.org/10.1002/wnan.1992openalex-snapshot
Insights into the formulation of lipid nanoparticles for the optimization of mRNA therapeutics
inferred← citeshttps://doi.org/10.1002/wnan.70025openalex-snapshot
Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles
inferred← citeshttps://doi.org/10.1007/7651_2021_362openalex-snapshot
CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines
inferred← citeshttps://doi.org/10.1007/82_2020_222openalex-snapshot
Advances in Development of mRNA-Based Therapeutics
inferred← citeshttps://doi.org/10.1007/978-1-0716-4051-7_14openalex-snapshot
Protocol for Delivery of CRISPR/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNA
inferred← citeshttps://doi.org/10.1007/978-3-030-73606-4_17openalex-snapshot
Applications of Nanobiotechnology in Overcoming Drought Stress in Crops
inferred← citeshttps://doi.org/10.1007/978-3-031-08415-7_3openalex-snapshot
Messenger RNA Therapeutics: Start of a New Era in Medicine
inferred← citeshttps://doi.org/10.1007/978-3-031-32967-8_1openalex-snapshot
Integrated Approaches to Agri-nanotechnology: Applications, Challenges, and Future Perspectives
inferred← citeshttps://doi.org/10.1007/978-3-031-81896-7_18openalex-snapshot
Emerging Tools and Technologies in Plant Nanotechnology Research
inferred← citeshttps://doi.org/10.1007/978-3-031-81896-7_8openalex-snapshot
Nanomaterials for Plant Growth Promotion
inferred← citeshttps://doi.org/10.1007/978-981-15-6453-6_63-1openalex-snapshot
Nanoproducts: Biomedical, Environmental, and Energy Applications
inferred← citeshttps://doi.org/10.1007/978-981-16-6305-5_4openalex-snapshot
Delivery Methods for CRISPR/Cas Reagents
inferred← citeshttps://doi.org/10.1007/978-981-16-8698-6_63openalex-snapshot
Nanoproducts: Biomedical, Environmental, and Energy Applications
inferred← citeshttps://doi.org/10.1007/978-981-19-0600-8_6openalex-snapshot
Genome Editing in Crops Via Homology-Directed Repair Using a Geminivirus-Based CRISPR/Cas9 System
inferred← citeshttps://doi.org/10.1007/978-981-19-2503-0_1openalex-snapshot
Emerging Trends of Nanoparticles in Sustainable Agriculture: Current and Future Perspectives
inferred← citeshttps://doi.org/10.1007/978-981-19-4308-9_14openalex-snapshot
Nanotechnological Approaches for Biofortification Concept and Concern in Cereal Crops
inferred← citeshttps://doi.org/10.1007/978-981-33-6158-4_10openalex-snapshot
Bioapplications of Nanomaterials
inferred← citeshttps://doi.org/10.1007/978-981-95-4709-8_12openalex-snapshot
Plant-Based Nanotechnology for Proteomic and Genomic: Current Trends, Approaches and Applications
inferred← citeshttps://doi.org/10.1007/978-981-95-4913-9_6openalex-snapshot
Future Developments of Nanoparticle’s Application for Plant Disease Management and Sustainable Yields
inferred← citeshttps://doi.org/10.1007/978-981-97-9873-5_12openalex-snapshot
Harnessing Nanopolysaccharides for Sustainable Agriculture and Environmental Protection
inferred← citeshttps://doi.org/10.1007/s00018-020-03725-2openalex-snapshot
Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect
inferred← citeshttps://doi.org/10.1007/s00109-020-01956-1openalex-snapshot
Strategies for simultaneous and successive delivery of RNA
inferred← citeshttps://doi.org/10.1007/s00335-026-10248-xopenalex-snapshot
The evolution of AI-integrated genome editing and its challenges
inferred← citeshttps://doi.org/10.1007/s00439-019-02028-2openalex-snapshot
Therapeutic application of the CRISPR system: current issues and new prospects
inferred← citeshttps://doi.org/10.1007/s00604-022-05460-wopenalex-snapshot
CRISPR/dCas9—surface-enhanced Raman scattering for the detection of drug resistance gene macB
inferred← citeshttps://doi.org/10.1007/s10439-026-04046-4openalex-snapshot
Miniaturized CRISPR: Ultra Compact Systems for In Vivo Delivery and Portable Diagnostics
inferred← citeshttps://doi.org/10.1007/s12033-023-00708-zopenalex-snapshot
Outlook on the Security and Potential Improvements of CRISPR–Cas9
inferred← citeshttps://doi.org/10.1007/s12195-018-0536-9openalex-snapshot
Lipid Polymer Hybrid Nanomaterials for mRNA Delivery
inferred← citeshttps://doi.org/10.1007/s12195-019-00573-4openalex-snapshot
Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles
inferred← citeshttps://doi.org/10.1007/s12195-020-00619-yopenalex-snapshot
Naturally Derived Membrane Lipids Impact Nanoparticle-Based Messenger RNA Delivery
inferred← citeshttps://doi.org/10.1007/s12247-020-09496-4openalex-snapshot
Efficiency of Chitosan-Coated PLGA Nanocarriers for Cellular Delivery of siRNA and CRISPR/Cas9 Complex
inferred← citeshttps://doi.org/10.1007/s12274-018-2082-0openalex-snapshot
Co-delivery of mRNA and SPIONs through amino-ester nanomaterials
inferred← citeshttps://doi.org/10.1007/s12274-018-2099-4openalex-snapshot
Design of synthetic materials for intracellular delivery of RNAs: From siRNA-mediated gene silencing to CRISPR/Cas gene editing
inferred← citeshttps://doi.org/10.1007/s12274-018-2146-1openalex-snapshot
Biomedical applications of mRNA nanomedicine
inferred← citeshttps://doi.org/10.1007/s12274-019-2308-9openalex-snapshot
Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer
inferred← citeshttps://doi.org/10.1007/s12274-022-4627-5openalex-snapshot
mRNA-based modalities for infectious disease management
inferred← citeshttps://doi.org/10.1007/s12274-024-6729-8openalex-snapshot
When mRNA meets gene editing
inferred← citeshttps://doi.org/10.1007/s12274-024-6748-5openalex-snapshot
Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing
inferred← citeshttps://doi.org/10.1007/s12668-025-02094-zopenalex-snapshot
CRISPR-Cas9-Loaded Lipid Nanoparticles: A Promising Strategy for Targeted Gene Editing and Therapy
inferred← citeshttps://doi.org/10.1007/s13258-019-00830-wopenalex-snapshot
Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems
inferred← citeshttps://doi.org/10.1007/s13346-017-0457-5openalex-snapshot
The fourth annual BRDS on genome editing and silencing for precision medicines
inferred← citeshttps://doi.org/10.1007/s40097-021-00446-1openalex-snapshot
Calcium-based nanomaterials and their interrelation with chitosan: optimization for pCRISPR delivery
inferred← citeshttps://doi.org/10.1007/s41204-022-00241-5openalex-snapshot
Sensors for agricultural pest management using nanotechnology/nanomaterials
inferred← citeshttps://doi.org/10.1007/s42114-026-01690-1openalex-snapshot
Fast mRNA delivery in vitro and in vivo enabled by magnetic responsive lipid nanoparticles
inferred← citeshttps://doi.org/10.1016/b978-0-08-102983-1.00008-9openalex-snapshot
Biomaterials for gene editing therapeutics
inferred← citeshttps://doi.org/10.1016/b978-0-12-817218-6.00018-8openalex-snapshot
Genetic modification of mice using CRISPR-Cas9: Best practices and practical concepts explained
inferred← citeshttps://doi.org/10.1016/b978-0-12-821595-1.00004-xopenalex-snapshot
RNA delivery for cancer gene therapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-823978-0.00007-1openalex-snapshot
Advances of nanotechnology in plant development and crop protection
inferred← citeshttps://doi.org/10.1016/b978-0-12-824010-6.00009-5openalex-snapshot
Targeted Therapeutics for Rare Disorders
inferred← citeshttps://doi.org/10.1016/b978-0-443-18500-7.00010-7openalex-snapshot
Nanobiotechnology in genetic engineering for abiotic stress resistance in crops
inferred← citeshttps://doi.org/10.1016/b978-0-443-18822-0.00001-3openalex-snapshot
Concepts and definitions in microbiology and nanotechnology in plant sciences
inferred← citeshttps://doi.org/10.1016/b978-0-443-22300-6.00035-8openalex-snapshot
Nanotherapies for the prevention and treatment of diet- and genetic-related diseases: A systematic review
inferred← citeshttps://doi.org/10.1016/bs.apha.2024.04.004openalex-snapshot
IVT-mRNA reprogramming of myeloid cells for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/bs.irn.2026.08.026openalex-snapshot
Novel therapies in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2021.01.002openalex-snapshot
The evolution and history of gene editing technologies
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2021.01.016openalex-snapshot
CRISPR-Cas9 in cancer therapeutics
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2023.12.015openalex-snapshot
Recent applications of RNA therapeutic in clinics
inferred← citeshttps://doi.org/10.1016/j.actbio.2020.07.027openalex-snapshot
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
inferred← citeshttps://doi.org/10.1016/j.actbio.2021.06.023openalex-snapshot
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
inferred← citeshttps://doi.org/10.1016/j.addr.2019.08.004openalex-snapshot
Brief update on endocytosis of nanomedicines
inferred← citeshttps://doi.org/10.1016/j.addr.2019.11.005openalex-snapshot
Rational designs of in vivo CRISPR-Cas delivery systems
inferred← citeshttps://doi.org/10.1016/j.addr.2020.03.001openalex-snapshot
Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing
inferred← citeshttps://doi.org/10.1016/j.addr.2020.03.005openalex-snapshot
Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach
inferred← citeshttps://doi.org/10.1016/j.addr.2020.04.002openalex-snapshot
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
inferred← citeshttps://doi.org/10.1016/j.addr.2020.05.010openalex-snapshot
In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
inferred← citeshttps://doi.org/10.1016/j.addr.2020.07.004openalex-snapshot
Progress and challenges towards CRISPR/Cas clinical translation
inferred← citeshttps://doi.org/10.1016/j.addr.2020.07.015openalex-snapshot
CRISPR/Cas systems to overcome challenges in developing the next generation of T cells for cancer therapy
inferred← citeshttps://doi.org/10.1016/j.addr.2020.07.018openalex-snapshot
DNA hydrogel-based gene editing and drug delivery systems
inferred← citeshttps://doi.org/10.1016/j.addr.2020.09.004openalex-snapshot
Non-viral strategies for delivering genome editing enzymes
inferred← citeshttps://doi.org/10.1016/j.addr.2020.10.014openalex-snapshot
Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing
inferred← citeshttps://doi.org/10.1016/j.addr.2021.05.013openalex-snapshot
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
inferred← citeshttps://doi.org/10.1016/j.addr.2021.113834openalex-snapshot
Nucleic acid delivery for therapeutic applications
inferred← citeshttps://doi.org/10.1016/j.addr.2021.114002openalex-snapshot
mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies
inferred← citeshttps://doi.org/10.1016/j.addr.2021.114041openalex-snapshot
Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114616openalex-snapshot
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114624openalex-snapshot
Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114872openalex-snapshot
Development of nucleic acid medicines based on chemical technology
inferred← citeshttps://doi.org/10.1016/j.addr.2023.115116openalex-snapshot
Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery
inferred← citeshttps://doi.org/10.1016/j.addr.2024.115359openalex-snapshot
Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications
inferred← citeshttps://doi.org/10.1016/j.addr.2026.115780openalex-snapshot
Technology for Nucleic Acid Delivery in the Treatment of Hematological Malignancies
inferred← citeshttps://doi.org/10.1016/j.apsb.2020.04.010openalex-snapshot
A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy
inferred← citeshttps://doi.org/10.1016/j.apsb.2022.12.013openalex-snapshot
Intelligent nanotherapeutic strategies for the delivery of CRISPR system
inferred← citeshttps://doi.org/10.1016/j.apsb.2023.03.001openalex-snapshot
mRNA delivery in cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.apsb.2025.10.040openalex-snapshot
A novel machine learning framework-based rapid screening of ionizable lipids in LNPs for highly-efficient mRNA expression
inferred← citeshttps://doi.org/10.1016/j.apsb.2026.02.014openalex-snapshot
Non-viral delivery of genome-editing tools for treatment of genetic disorders
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2022.01.011openalex-snapshot
Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
inferred← citeshttps://doi.org/10.1016/j.bioadv.2025.214667openalex-snapshot
Recent advances in engineering approaches for delivery of mRNA-based therapeutics
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2018.04.020openalex-snapshot
Far-red light-mediated programmable anti-cancer gene delivery in cooperation with photodynamic therapy
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2018.04.031openalex-snapshot
Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2019.119291openalex-snapshot
RNA delivery biomaterials for the treatment of genetic and rare diseases
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2019.119302openalex-snapshot
In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2020.120275openalex-snapshot
Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2020.120282openalex-snapshot
Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2020.120580openalex-snapshot
PLGA-Nanoparticles for Intracellular Delivery of the CRISPR-Complex to Elevate Fetal Globin Expression in Erythroid Cells
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.120793openalex-snapshot
Systemic delivery of CRISPR/Cas9 to hepatic tumors for cancer treatment using altered tropism of lentiviral vector
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2025.123671openalex-snapshot
Investigating the functional contributions of phospholipids in selective organ targeting lipid nanoparticles
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2020.107534openalex-snapshot
The challenge and prospect of mRNA therapeutics landscape
inferred← citeshttps://doi.org/10.1016/j.blre.2024.101185openalex-snapshot
Revolutionising healing: Gene Editing's breakthrough against sickle cell disease
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.04.040openalex-snapshot
Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.ccr.2018.07.001openalex-snapshot
Non-viral gene therapy using multifunctional nanoparticles: Status, challenges, and opportunities
inferred← citeshttps://doi.org/10.1016/j.ccr.2023.215172openalex-snapshot
Vector enabled CRISPR gene editing – A revolutionary strategy for targeting the diversity of brain pathologies
inferred← citeshttps://doi.org/10.1016/j.cej.2022.135116openalex-snapshot
Non-viral nanocarriers for CRISPR-Cas9 gene editing system delivery
inferred← citeshttps://doi.org/10.1016/j.cej.2024.155596openalex-snapshot
DPA-Zn enables targeting and bypassing endosomal trapping delivery of a genome-editing system into cancer cells via phosphatidylserine-mediated endocytic pathway
inferred← citeshttps://doi.org/10.1016/j.celbio.2026.100535openalex-snapshot
Genomic deletion of P-glycoprotein from gliomas via the focused ultrasound delivery of a duplex CRISPR-Cas9 ribonucleoprotein system
inferred← citeshttps://doi.org/10.1016/j.cell.2022.03.045openalex-snapshot
Therapeutic in vivo delivery of gene editing agents
inferred← citeshttps://doi.org/10.1016/j.celrep.2018.02.014openalex-snapshot
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
inferred← citeshttps://doi.org/10.1016/j.chemosphere.2021.132533openalex-snapshot
The dichotomy of nanotechnology as the cutting edge of agriculture: Nano-farming as an asset versus nanotoxicity
inferred← citeshttps://doi.org/10.1016/j.cjche.2021.02.009openalex-snapshot
Enhancing gene editing efficiency for cells by CRISPR/Cas9 system-loaded multilayered nanoparticles assembled via microfluidics
inferred← citeshttps://doi.org/10.1016/j.cld.2023.05.006openalex-snapshot
Targeting Hepatitis B Virus DNA Using Designer Gene Editors
inferred← citeshttps://doi.org/10.1016/j.clinre.2018.05.001openalex-snapshot
Potentials of CRISPR in liver research and therapy
inferred← citeshttps://doi.org/10.1016/j.cll.2020.02.008openalex-snapshot
Therapeutic Gene Editing with CRISPR
inferred← citeshttps://doi.org/10.1016/j.cobme.2018.08.001openalex-snapshot
Testing thousands of nanoparticles in vivo using DNA barcodes
inferred← citeshttps://doi.org/10.1016/j.cobme.2018.08.002openalex-snapshot
Debugging the genetic code: Non-viral in vivo delivery of therapeutic genome editing technologies
inferred← citeshttps://doi.org/10.1016/j.coph.2017.09.018openalex-snapshot
Transformative therapies for rare CFTR missense alleles
inferred← citeshttps://doi.org/10.1016/j.csbj.2020.07.015openalex-snapshot
Novel zwitterionic vectors: Multi-functional delivery systems for therapeutic genes and drugs
inferred← citeshttps://doi.org/10.1016/j.ddmod.2017.02.009openalex-snapshot
Cancer gene therapy: innovations in therapeutic delivery of CRISPR-Cas9
inferred← citeshttps://doi.org/10.1016/j.ebiom.2024.105266openalex-snapshot
Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment
inferred← citeshttps://doi.org/10.1016/j.ejpb.2021.03.011openalex-snapshot
Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination
inferred← citeshttps://doi.org/10.1016/j.ejpb.2023.10.006openalex-snapshot
The mixing method used to formulate lipid nanoparticles affects mRNA delivery efficacy and organ tropism
inferred← citeshttps://doi.org/10.1016/j.ejpb.2024.114203openalex-snapshot
Recent trends in the delivery of RNA drugs: Beyond the liver, more than vaccine
inferred← citeshttps://doi.org/10.1016/j.gendis.2026.102484openalex-snapshot
The CRISPR/Cas technology landscape: From molecular mechanisms to multidisciplinary applications
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.149180openalex-snapshot
CRISPR-Cas mediated targeting of resistance genes for combating ESKAPE pathogen infections: A Review
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.149291openalex-snapshot
Zein-based drug delivery carriers for biomedical applications: An updated overview
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2021.121020openalex-snapshot
mRNA delivery via non-viral carriers for biomedical applications
showing the first 200 of 536
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.